« Approval Rates Higher for Small Firms in Top 50 - Tufts CSDD Report | Main | Would EU Vouchers Spur Neglected Disease Drug Development? »

09/10/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0134873613f5970c

Listed below are links to weblogs that reference Genzyme: We aren't taking $69/share but are Cutting 1,000 Jobs!:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

More details on this story from the Pharmalot blog
http://www.pharmalot.com/2010/09/lonza-axes-100-jobs-as-plant-is-phased-out/

bigredbruce

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

August 2014

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31            

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada